Fig. 3From: Validation of the Toronto hepatocellular carcinoma risk index for patients with cirrhosis in China: a retrospective cohort studyCumulative incidence of HCC by THRI risk group. The cumulative incidence of HCC is shown for the low-risk group (THRI < 120), intermediate-risk group (THRI 120–240), and high-risk group (THRI > 240). Cumulative incidence was compared between groups using a log-rank test (p < 0.001, low-risk vs. intermediate-risk with p = 0.191, intermediate-risk vs. high-risk with p < 0.001, and low-risk vs. high-risk with p = 0.022)Back to article page